Back to search

University of Nevada - Reno

The IBD 100: Does It Really Beat "The Market"?

Abstract

dc:description.abstract

IBD 100 proclaims itself to be the number one investing strategy and that it has yielded far better returns since its inception than S&P500 during the same period. I examine the validity of these claims by analyzing the performance of IBD100 stock recommendations made between July2005 and Dec 2009. Although IBD yielded 5.54% in comparison to -8.18% by S&P500 during the study period, deeper analysis of the relative performance to the benchmark index reveals that IBD100 stock are smaller and more growth oriented than those of S&P500 and that when comparing the returns of the IBD 100 to more appropriate benchmarks, the excess performance disappears.

Degree

thesis:*
Level thesis:degree_level
Master's Degree
Department thesis:degree_department
Business Administration
Year dc:date.issued
2010

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gulati, Bharman
Advisor dc:contributor.advisor
  • Stone, Gregory R.
Committee members dc:contributor.committeemember
  • Bhargava, Rahul
  • Nichols, Mark W

Subjects

dc:subject × 6

Rights

dc:rights
Statement dc:rights
  • In Copyright(All Rights Reserved)
  • Author(s)

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/11714/4381

Chain of custody

source
Harvested from
University of Nevada - Reno
Base URL
scholarwolf.unr.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Gulati, Bharman. The IBD 100: Does It Really Beat "The Market"?. Master's Degree thesis, 2010. http://hdl.handle.net/11714/4381